| interleukin 6 production | GO:0032635 | 37 | 1.000 | Human |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 44 | 1.000 | Human |
| cellular response to bacterial lipoprotein | GO:0071220 | 3 | 1.000 | |
| negative regulation of tumor necrosis factor superfamily cytokine production | GO:1903556 | 20 | 1.000 | Human |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.999 | |
| negative regulation of tumor necrosis factor production | GO:0032720 | 20 | 0.999 | Human |
| activation of innate immune response | GO:0002218 | 55 | 0.999 | Human |
| innate immune response activating signal transduction | GO:0002758 | 48 | 0.999 | Human |
| toll like receptor 2 signaling pathway | GO:0034134 | 4 | 0.998 | Human |
| regulation of cytokine production | GO:0001817 | 232 | 0.996 | Human |
| response to biotic stimulus | GO:0009607 | 276 | 0.996 | Human Mouse |
| negative regulation of interleukin 6 production | GO:0032715 | 13 | 0.995 | Human |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 51 | 0.995 | |
| positive regulation of toll like receptor 4 signaling pathway | GO:0034145 | 6 | 0.995 | |
| activation of protein kinase activity | GO:0032147 | 90 | 0.995 | Human |
| cytokine production | GO:0001816 | 247 | 0.994 | Human |
| regulation of tumor necrosis factor production | GO:0032680 | 43 | 0.994 | Human |
| response to peptidoglycan | GO:0032494 | 3 | 0.994 | |
| cellular response to lipopolysaccharide | GO:0071222 | 57 | 0.994 | Human Mouse |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.993 | Human |
| cellular response to biotic stimulus | GO:0071216 | 71 | 0.993 | Human Mouse |
| cytokine mediated signaling pathway | GO:0019221 | 109 | 0.993 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 48 | 0.992 | Human |
| positive regulation of lipopolysaccharide mediated signaling pathway | GO:0031666 | 4 | 0.992 | |
| growth of symbiont in host | GO:0044117 | 1 | 0.992 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 62 | 0.988 | Human Mouse |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.986 | |
| positive regulation of toll like receptor signaling pathway | GO:0034123 | 10 | 0.984 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 45 | 0.983 | Human |
| positive regulation of innate immune response | GO:0045089 | 79 | 0.979 | Human |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 26 | 0.978 | Human Mouse |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 1 | 0.975 | |
| mapk cascade | GO:0000165 | 288 | 0.974 | Human |
| response to bacterium | GO:0009617 | 144 | 0.974 | Human Mouse |
| response to molecule of bacterial origin | GO:0002237 | 82 | 0.973 | Human Mouse |
| response to lipoteichoic acid | GO:0070391 | 3 | 0.973 | |
| positive regulation of defense response | GO:0031349 | 87 | 0.970 | Human |
| response to lipopolysaccharide | GO:0032496 | 70 | 0.967 | Human Mouse |
| positive regulation of nik nf kappab signaling | GO:1901224 | 10 | 0.966 | Human |
| immune response activating signal transduction | GO:0002757 | 90 | 0.965 | Human |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.964 | Human |
| regulation of nik nf kappab signaling | GO:1901222 | 11 | 0.964 | Human |
| regulation of interleukin 6 production | GO:0032675 | 37 | 0.962 | Human |
| toll like receptor signaling pathway | GO:0002224 | 25 | 0.961 | Human |
| response to other organism | GO:0051707 | 261 | 0.961 | Human Mouse |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.958 | Human |
| activation of nf kappab inducing kinase activity | GO:0007250 | 9 | 0.958 | Human |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.951 | Human |
| tumor necrosis factor production | GO:0032640 | 43 | 0.950 | Human |
| positive regulation of interleukin 23 production | GO:0032747 | 4 | 0.950 | |
| regulation of immune response | GO:0050776 | 201 | 0.949 | Human |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.944 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.943 | Human |
| interleukin 1 mediated signaling pathway | GO:0070498 | 12 | 0.940 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 57 | 0.934 | Human |
| positive regulation of toll like receptor 2 signaling pathway | GO:0034137 | 2 | 0.922 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.917 | Human Mouse |
| regulation of mapk cascade | GO:0043408 | 262 | 0.916 | Human |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.915 | Human Mouse |
| regulation of toll like receptor signaling pathway | GO:0034121 | 17 | 0.910 | |
| cellular response to lipid | GO:0071396 | 127 | 0.905 | Human Mouse |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.904 | Human |
| chemokine biosynthetic process | GO:0042033 | 4 | 0.903 | |
| response to cytokine | GO:0034097 | 232 | 0.901 | |
| modulation of growth of symbiont involved in interaction with host | GO:0044144 | 2 | 0.900 | |
| regulation of interleukin 12 production | GO:0032655 | 15 | 0.899 | Human |
| growth involved in symbiotic interaction | GO:0044110 | 2 | 0.897 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.887 | Human |
| positive regulation of toll like receptor 3 signaling pathway | GO:0034141 | 1 | 0.879 | |
| growth of symbiont involved in interaction with host | GO:0044116 | 2 | 0.876 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.876 | Human |
| activation of immune response | GO:0002253 | 114 | 0.874 | Human |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 81 | 0.873 | |
| response to interleukin 1 | GO:0070555 | 47 | 0.868 | |
| regulation of innate immune response | GO:0045088 | 97 | 0.859 | Human |
| regulation of kinase activity | GO:0043549 | 314 | 0.849 | Human |
| negative regulation of macrophage cytokine production | GO:0010936 | 3 | 0.846 | |
| chemokine metabolic process | GO:0050755 | 4 | 0.840 | |
| response to lipid | GO:0033993 | 206 | 0.829 | Human Mouse |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.817 | Human |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.816 | |
| negative regulation of protein complex disassembly | GO:0043242 | 20 | 0.814 | Human |
| response to oxygen containing compound | GO:1901700 | 369 | 0.813 | Human Mouse |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.813 | Human |
| antifungal humoral response | GO:0019732 | 2 | 0.811 | |
| regulation of interleukin 17 production | GO:0032660 | 12 | 0.804 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.802 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.797 | Human |
| defense response | GO:0006952 | 315 | 0.797 | Human |
| interleukin 17 production | GO:0032620 | 12 | 0.788 | |
| regulation of toll like receptor 2 signaling pathway | GO:0034135 | 2 | 0.785 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.780 | |
| negative regulation of reactive oxygen species metabolic process | GO:2000378 | 11 | 0.778 | |
| regulation of lipopolysaccharide mediated signaling pathway | GO:0031664 | 13 | 0.777 | |
| innate immune response | GO:0045087 | 178 | 0.774 | Human |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.764 | |
| regulation of chemokine biosynthetic process | GO:0045073 | 4 | 0.761 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.752 | Human |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.740 | Human |
| positive regulation of chemokine production | GO:0032722 | 22 | 0.723 | |
| smooth muscle cell proliferation | GO:0048659 | 28 | 0.709 | |
| positive regulation of stress activated protein kinase signaling cascade | GO:0070304 | 61 | 0.704 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 25 | 0.700 | |
| positive regulation of map kinase activity | GO:0043406 | 80 | 0.700 | |
| response to bacterial lipoprotein | GO:0032493 | 3 | 0.694 | |
| positive regulation of chemokine biosynthetic process | GO:0045080 | 3 | 0.691 | |
| toll like receptor 4 signaling pathway | GO:0034142 | 12 | 0.690 | |
| regulation of fat cell differentiation | GO:0045598 | 23 | 0.689 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.685 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.684 | |
| positive regulation of jun kinase activity | GO:0043507 | 23 | 0.677 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.676 | Human |
| regulation of response to cytokine stimulus | GO:0060759 | 46 | 0.642 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.639 | Human |
| negative regulation of cholesterol transport | GO:0032375 | 8 | 0.638 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.624 | |
| response to diacyl bacterial lipopeptide | GO:0071724 | 2 | 0.591 | |
| negative regulation of interleukin 12 production | GO:0032695 | 6 | 0.590 | Human |
| immune response | GO:0006955 | 307 | 0.586 | Human |
| organic hydroxy compound transport | GO:0015850 | 63 | 0.568 | |
| negative regulation of growth | GO:0045926 | 97 | 0.554 | |
| nitric oxide biosynthetic process | GO:0006809 | 20 | 0.545 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.542 | |
| regulation of nitric oxide biosynthetic process | GO:0045428 | 17 | 0.540 | |
| lipid localization | GO:0010876 | 106 | 0.519 | |
| negative regulation of mapk cascade | GO:0043409 | 56 | 0.511 | Human |
| jnk cascade | GO:0007254 | 80 | 0.509 | |
| cellular response to bacterial lipopeptide | GO:0071221 | 3 | 0.497 | |
| positive regulation of smooth muscle cell proliferation | GO:0048661 | 14 | 0.495 | |
| negative regulation of cholesterol efflux | GO:0090370 | 2 | 0.494 | |
| regulation of cytokine mediated signaling pathway | GO:0001959 | 41 | 0.492 | |
| detection of diacyl bacterial lipopeptide | GO:0042496 | 2 | 0.476 | |
| i kappab phosphorylation | GO:0007252 | 7 | 0.472 | |
| regulation of cytokine production involved in immune response | GO:0002718 | 22 | 0.462 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.460 | Human |
| positive regulation of jnk cascade | GO:0046330 | 52 | 0.458 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.457 | |
| cholesterol efflux | GO:0033344 | 28 | 0.456 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 3 | 0.442 | |
| negative regulation of growth of symbiont involved in interaction with host | GO:0044146 | 2 | 0.440 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.440 | |
| regulation of smooth muscle cell proliferation | GO:0048660 | 28 | 0.436 | |
| macrophage cytokine production | GO:0010934 | 4 | 0.428 | |
| regulation of jun kinase activity | GO:0043506 | 27 | 0.427 | |
| regulation of map kinase activity | GO:0043405 | 108 | 0.424 | Human |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.402 | Human |
| immune effector process | GO:0002252 | 159 | 0.402 | |
| positive regulation of interferon alpha biosynthetic process | GO:0045356 | 4 | 0.397 | |
| interleukin 12 production | GO:0032615 | 15 | 0.385 | Human |
| regulation of cell cycle | GO:0051726 | 393 | 0.380 | |
| fat cell differentiation | GO:0045444 | 32 | 0.380 | |
| defense response to bacterium | GO:0042742 | 63 | 0.375 | |
| cellular component disassembly | GO:0022411 | 92 | 0.370 | Human |
| detection of bacterial lipoprotein | GO:0042494 | 3 | 0.363 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.360 | |
| macromolecular complex disassembly | GO:0032984 | 60 | 0.359 | Human |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.358 | |
| negative regulation of protein catabolic process | GO:0042177 | 59 | 0.354 | Human |
| production of molecular mediator of immune response | GO:0002440 | 37 | 0.352 | |
| cellular response to uv | GO:0034644 | 32 | 0.350 | |
| type i interferon biosynthetic process | GO:0045351 | 4 | 0.350 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.341 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.339 | Human |
| negative regulation of nitric oxide biosynthetic process | GO:0045019 | 5 | 0.332 | |
| regulation of stress activated protein kinase signaling cascade | GO:0070302 | 85 | 0.325 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.320 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 60 | 0.319 | |
| positive regulation of protein binding | GO:0032092 | 24 | 0.318 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.314 | Human |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.310 | |
| negative regulation of cytokine production involved in immune response | GO:0002719 | 13 | 0.305 | |
| negative regulation of cytokine mediated signaling pathway | GO:0001960 | 22 | 0.303 | |
| response to triacyl bacterial lipopeptide | GO:0071725 | 2 | 0.300 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.291 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.290 | |
| regulation of jnk cascade | GO:0046328 | 73 | 0.290 | |
| response to fungus | GO:0009620 | 4 | 0.286 | |
| regulation of autophagy | GO:0010506 | 52 | 0.279 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.271 | Human |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 52 | 0.269 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.266 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.266 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.263 | Human |
| regulation of growth | GO:0040008 | 165 | 0.262 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.256 | Human |
| mitotic cell cycle | GO:0000278 | 326 | 0.248 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.244 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.243 | |
| stress activated mapk cascade | GO:0051403 | 93 | 0.242 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 29 | 0.241 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.239 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.239 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.239 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.236 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 48 | 0.232 | |
| lipid transport | GO:0006869 | 90 | 0.232 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.231 | Human |
| autophagy | GO:0006914 | 88 | 0.228 | |
| positive regulation of interferon beta biosynthetic process | GO:0045359 | 4 | 0.228 | |
| cell growth | GO:0016049 | 160 | 0.217 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.217 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.217 | |
| regulation of cell motility | GO:2000145 | 299 | 0.215 | |
| type i interferon production | GO:0032606 | 27 | 0.213 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 22 | 0.213 | |
| rna stabilization | GO:0043489 | 18 | 0.213 | |
| hemopoiesis | GO:0030097 | 180 | 0.209 | |
| positive regulation of interleukin 6 production | GO:0032755 | 21 | 0.204 | |
| positive regulation of interleukin 8 production | GO:0032757 | 36 | 0.200 | |
| nitric oxide metabolic process | GO:0046209 | 22 | 0.198 | |
| positive regulation of lymphocyte activation | GO:0051251 | 73 | 0.197 | |
| protein oligomerization | GO:0051259 | 173 | 0.187 | Human |
| interferon alpha biosynthetic process | GO:0045349 | 4 | 0.186 | |
| regulation of cell growth | GO:0001558 | 135 | 0.185 | |
| cellular response to diacyl bacterial lipopeptide | GO:0071726 | 2 | 0.184 | |
| positive regulation of autophagy | GO:0010508 | 24 | 0.182 | |
| protein catabolic process | GO:0030163 | 325 | 0.182 | Human |
| nucleotide binding oligomerization domain containing signaling pathway | GO:0070423 | 4 | 0.182 | |
| positive regulation of mononuclear cell proliferation | GO:0032946 | 47 | 0.177 | |
| immunoglobulin secretion | GO:0048305 | 1 | 0.175 | |
| cellular response to radiation | GO:0071478 | 65 | 0.173 | |
| regulation of cell activation | GO:0050865 | 125 | 0.173 | |
| cytokine production involved in immune response | GO:0002367 | 27 | 0.170 | |
| lymphocyte mediated immunity | GO:0002449 | 48 | 0.170 | |
| primary neural tube formation | GO:0014020 | 3 | 0.166 | |
| defense response to gram positive bacterium | GO:0050830 | 29 | 0.163 | |
| defense response to fungus | GO:0050832 | 4 | 0.162 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.162 | |
| regulation of protein binding | GO:0043393 | 66 | 0.160 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.157 | Human |
| lymphocyte activation | GO:0046649 | 133 | 0.156 | |
| response to radiation | GO:0009314 | 151 | 0.156 | |
| response to uv | GO:0009411 | 73 | 0.152 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 35 | 0.149 | |
| lipid storage | GO:0019915 | 28 | 0.147 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.146 | Human |
| epithelium development | GO:0060429 | 227 | 0.145 | |
| regulation of rna stability | GO:0043487 | 23 | 0.143 | |
| cholesterol transport | GO:0030301 | 39 | 0.142 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.142 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.140 | |
| immune system development | GO:0002520 | 195 | 0.139 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 42 | 0.139 | |
| regulation of protein transport | GO:0051223 | 213 | 0.132 | |
| protein complex disassembly | GO:0043241 | 52 | 0.131 | Human |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.130 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.127 | |
| positive regulation of interleukin 6 biosynthetic process | GO:0045410 | 1 | 0.127 | |
| cellular response to triacyl bacterial lipopeptide | GO:0071727 | 2 | 0.127 | |
| positive regulation of humoral immune response | GO:0002922 | 3 | 0.124 | |
| growth | GO:0040007 | 202 | 0.124 | |
| chemokine production | GO:0032602 | 32 | 0.123 | |
| myeloid leukocyte cytokine production | GO:0061082 | 5 | 0.123 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.121 | Human |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.120 | Human |
| regulation of tolerance induction | GO:0002643 | 4 | 0.120 | |
| leukocyte proliferation | GO:0070661 | 74 | 0.114 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.113 | |
| negative regulation of multi organism process | GO:0043901 | 92 | 0.112 | |
| regulation of lipid storage | GO:0010883 | 21 | 0.109 | |
| response to heat | GO:0009408 | 21 | 0.107 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.106 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.105 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.105 | |
| detection of bacterial lipopeptide | GO:0070340 | 3 | 0.105 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.103 | Human |
| inflammatory response | GO:0006954 | 79 | 0.102 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.102 | |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.102 | Human |
| positive regulation of interleukin 17 production | GO:0032740 | 8 | 0.101 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.100 | |
| regulation of chemokine c x c motif ligand 2 production | GO:2000341 | 2 | 0.100 | |
| cellular response to oxygen levels | GO:0071453 | 55 | 0.099 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.099 | |
| negative regulation of immune response | GO:0050777 | 40 | 0.098 | |
| muscle cell proliferation | GO:0033002 | 35 | 0.097 | |
| mrna stabilization | GO:0048255 | 18 | 0.097 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 46 | 0.097 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.097 | |
| positive regulation of chemotaxis | GO:0050921 | 57 | 0.097 | |
| response to light stimulus | GO:0009416 | 87 | 0.097 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.096 | |
| cell activation | GO:0001775 | 213 | 0.094 | |
| cellular response to heat | GO:0034605 | 14 | 0.094 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.093 | |
| regulation of locomotion | GO:0040012 | 329 | 0.092 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 25 | 0.091 | |
| cytokine biosynthetic process | GO:0042089 | 37 | 0.089 | |
| negative regulation of map kinase activity | GO:0043407 | 27 | 0.087 | Human |
| regulation of nucleocytoplasmic transport | GO:0046822 | 98 | 0.087 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.087 | |
| regulation of macrophage cytokine production | GO:0010935 | 4 | 0.087 | |
| regulation of defense response | GO:0031347 | 154 | 0.086 | Human |
| negative regulation of immune system process | GO:0002683 | 136 | 0.085 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.085 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.084 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.083 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.082 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 40 | 0.082 | |
| regulation of interferon alpha biosynthetic process | GO:0045354 | 4 | 0.082 | |
| negative regulation of production of molecular mediator of immune response | GO:0002701 | 13 | 0.080 | |
| nik nf kappab signaling | GO:0038061 | 12 | 0.077 | Human |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.077 | Human |
| response to bacterial lipopeptide | GO:0070339 | 3 | 0.076 | |
| positive regulation of t cell cytokine production | GO:0002726 | 4 | 0.076 | |
| response to hypoxia | GO:0001666 | 96 | 0.075 | |
| toll like receptor 3 signaling pathway | GO:0034138 | 4 | 0.073 | |
| protein ubiquitination | GO:0016567 | 314 | 0.073 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.072 | |
| sterol transport | GO:0015918 | 39 | 0.072 | |
| cellular response to lipoteichoic acid | GO:0071223 | 3 | 0.071 | |
| regulation of lipid transport | GO:0032368 | 44 | 0.071 | |
| nf kappab import into nucleus | GO:0042348 | 22 | 0.070 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.070 | |
| cytokine metabolic process | GO:0042107 | 38 | 0.070 | |
| regulation of secretion | GO:0051046 | 194 | 0.070 | |
| regulation of toll like receptor 3 signaling pathway | GO:0034139 | 2 | 0.070 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.069 | |
| positive regulation of interleukin 8 biosynthetic process | GO:0045416 | 8 | 0.068 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.068 | |
| regulation of immunoglobulin production | GO:0002637 | 4 | 0.068 | |
| positive regulation of nf kappab import into nucleus | GO:0042346 | 13 | 0.067 | |
| regulation of protein homodimerization activity | GO:0043496 | 9 | 0.067 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.067 | |
| negative regulation of growth of symbiont in host | GO:0044130 | 1 | 0.066 | |
| maintenance of location | GO:0051235 | 112 | 0.065 | |
| neural tube formation | GO:0001841 | 3 | 0.065 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.064 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.064 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.064 | |
| cellular response to light stimulus | GO:0071482 | 34 | 0.064 | |
| negative regulation of tumor necrosis factor mediated signaling pathway | GO:0010804 | 7 | 0.062 | |
| negative regulation of defense response | GO:0031348 | 47 | 0.061 | |
| regulation of sterol transport | GO:0032371 | 21 | 0.060 | |
| regulation of cell migration | GO:0030334 | 289 | 0.059 | |
| interleukin 1 production | GO:0032612 | 26 | 0.058 | |
| 3 utr mediated mrna stabilization | GO:0070935 | 8 | 0.058 | |
| leukocyte activation | GO:0045321 | 164 | 0.058 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.058 | |
| negative regulation of toll signaling pathway | GO:0045751 | 1 | 0.056 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.056 | Human |
| negative regulation of protein ubiquitination | GO:0031397 | 35 | 0.055 | |
| regulation of interleukin 2 production | GO:0032663 | 19 | 0.055 | |
| regulation of interleukin 6 biosynthetic process | GO:0045408 | 5 | 0.055 | |
| myeloid leukocyte activation | GO:0002274 | 34 | 0.054 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.054 | |
| detection of triacyl bacterial lipopeptide | GO:0042495 | 2 | 0.054 | |
| positive regulation of granulocyte chemotaxis | GO:0071624 | 9 | 0.053 | |
| positive regulation of b cell proliferation | GO:0030890 | 12 | 0.053 | |
| nucleotide binding oligomerization domain containing 2 signaling pathway | GO:0070431 | 4 | 0.053 | |
| positive regulation of cytokine mediated signaling pathway | GO:0001961 | 12 | 0.053 | |
| positive regulation of interleukin 1 production | GO:0032732 | 14 | 0.053 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.053 | |
| antimicrobial humoral response | GO:0019730 | 26 | 0.053 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.052 | |
| response to oxygen levels | GO:0070482 | 100 | 0.051 | |
| protein import | GO:0017038 | 130 | 0.051 | |
| interleukin 6 biosynthetic process | GO:0042226 | 5 | 0.051 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.050 | |
| b cell activation | GO:0042113 | 33 | 0.049 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.049 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 24 | 0.049 | |
| myeloid dendritic cell activation | GO:0001773 | 4 | 0.049 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.048 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.048 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.047 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.046 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.046 | |
| negative regulation of transport | GO:0051051 | 176 | 0.046 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.046 | |
| regulation of binding | GO:0051098 | 111 | 0.044 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 158 | 0.044 | |
| amine metabolic process | GO:0009308 | 44 | 0.044 | |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 15 | 0.044 | |
| regulation of interleukin 1 production | GO:0032652 | 21 | 0.043 | |
| regulation of alkaline phosphatase activity | GO:0010692 | 2 | 0.043 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 54 | 0.042 | |
| regulation of chemokine production | GO:0032642 | 31 | 0.042 | |
| myeloid dendritic cell differentiation | GO:0043011 | 3 | 0.042 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.041 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.041 | |
| regulation of tumor necrosis factor mediated signaling pathway | GO:0010803 | 12 | 0.041 | |
| locomotory behavior | GO:0007626 | 1 | 0.041 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.041 | |
| regulation of interleukin 1 mediated signaling pathway | GO:2000659 | 3 | 0.041 | |
| positive regulation of antimicrobial humoral response | GO:0002760 | 1 | 0.040 | |
| regulation of mononuclear cell proliferation | GO:0032944 | 65 | 0.040 | |
| establishment of endothelial barrier | GO:0061028 | 16 | 0.040 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.039 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 9 | 0.039 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.039 | |
| response to wounding | GO:0009611 | 168 | 0.038 | |
| tumor necrosis factor mediated signaling pathway | GO:0033209 | 27 | 0.038 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.038 | |
| leukocyte migration | GO:0050900 | 107 | 0.038 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.037 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.037 | |
| t helper 1 type immune response | GO:0042088 | 8 | 0.037 | |
| interleukin 8 production | GO:0032637 | 51 | 0.036 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.036 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.036 | |
| type i interferon signaling pathway | GO:0060337 | 11 | 0.035 | |
| regulation of cell division | GO:0051302 | 116 | 0.035 | |
| regulation of inflammatory response | GO:0050727 | 46 | 0.034 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.034 | |
| negative regulation of toll like receptor 3 signaling pathway | GO:0034140 | 2 | 0.034 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.034 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 11 | 0.032 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.032 | |
| regulation of antimicrobial humoral response | GO:0002759 | 1 | 0.032 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.032 | |
| response to exogenous dsrna | GO:0043330 | 10 | 0.031 | |
| regulation of interferon beta production | GO:0032648 | 22 | 0.031 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.031 | |
| positive regulation of neutrophil migration | GO:1902624 | 7 | 0.030 | |
| cellular response to tumor necrosis factor | GO:0071356 | 63 | 0.030 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.030 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.030 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.029 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.029 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.029 | |
| positive regulation of response to external stimulus | GO:0032103 | 88 | 0.029 | |
| cellular homeostasis | GO:0019725 | 196 | 0.029 | |
| neurotransmitter secretion | GO:0007269 | 4 | 0.029 | |
| protein homooligomerization | GO:0051260 | 100 | 0.029 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.028 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.028 | |
| tube closure | GO:0060606 | 3 | 0.028 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 9 | 0.028 | |
| anatomical structure homeostasis | GO:0060249 | 100 | 0.028 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.027 | |
| cellular response to interleukin 1 | GO:0071347 | 35 | 0.027 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.027 | |
| endothelial cell development | GO:0001885 | 18 | 0.027 | |
| circadian behavior | GO:0048512 | 2 | 0.026 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.026 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.025 | |
| protein targeting | GO:0006605 | 187 | 0.025 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.025 | |
| negative regulation of smooth muscle cell proliferation | GO:0048662 | 14 | 0.025 | |
| single organism cellular localization | GO:1902580 | 332 | 0.025 | |
| regulation of b cell activation | GO:0050864 | 24 | 0.025 | |
| regulation of cholesterol efflux | GO:0010874 | 11 | 0.025 | |
| antigen processing and presentation | GO:0019882 | 33 | 0.024 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.024 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.024 | Human |
| neuromuscular junction development | GO:0007528 | 3 | 0.024 | |
| atp metabolic process | GO:0046034 | 176 | 0.024 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.024 | |
| cellular response to mechanical stimulus | GO:0071260 | 39 | 0.024 | |
| regulation of protein localization | GO:0032880 | 296 | 0.024 | |
| positive regulation of binding | GO:0051099 | 45 | 0.024 | |
| positive regulation of b cell activation | GO:0050871 | 17 | 0.023 | |
| response to temperature stimulus | GO:0009266 | 22 | 0.023 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 158 | 0.023 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.023 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.022 | |
| response to mechanical stimulus | GO:0009612 | 51 | 0.022 | |
| regulation of b cell proliferation | GO:0030888 | 18 | 0.022 | |
| tube morphogenesis | GO:0035239 | 95 | 0.022 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.022 | |
| positive regulation of leukocyte activation | GO:0002696 | 80 | 0.022 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.022 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.022 | |
| cell cell signaling | GO:0007267 | 155 | 0.022 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 158 | 0.022 | |
| regulation of mitosis | GO:0007088 | 63 | 0.022 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.022 | |
| female gamete generation | GO:0007292 | 2 | 0.022 | |
| organic anion transport | GO:0015711 | 103 | 0.021 | |
| defense response to virus | GO:0051607 | 71 | 0.021 | |
| positive regulation of protein homodimerization activity | GO:0090073 | 5 | 0.021 | |
| leukocyte chemotaxis | GO:0030595 | 76 | 0.021 | |
| positive regulation of tumor necrosis factor production | GO:0032760 | 21 | 0.021 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.021 | |
| vasculature development | GO:0001944 | 181 | 0.021 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.021 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.021 | |
| positive regulation of leukocyte migration | GO:0002687 | 46 | 0.021 | |
| regulation of interleukin 10 production | GO:0032653 | 16 | 0.021 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.021 | |
| positive regulation of monocyte chemotactic protein 1 production | GO:0071639 | 3 | 0.020 | |
| interleukin 2 production | GO:0032623 | 20 | 0.020 | |
